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Introduction: We developed hydroxyapatite (HA) 
granules made from local raw materials (GranuMaS™), 
which have been fabricated using a novel method 
(Patent (Pending) No. PI 2004 0748). GranuMaS™ 
have been fully characterized using X-ray diffraction, 
scanning electron microscopy, energy dispersive x-ray, 
Fourier transform infra-red spectroscopy and 
inductively coupled plasma methods. It has also been 
shown to comply with the ASTM F1185 - 88 (1993) 
specification standards. 
Biocompatibility studies have been performed on the 
product, which include neutral red cytotoxicity assay 
using cultured fibroblast and CRL-1427 osteoblast cells; 
MTT (Tetrazolium Salt) assay; cytotoxicity studies for 
apoptosis using Acridine Orange / Propidium Iodide 
(AO/PI) dual staining of V79 cells in DMEM; and 
COMET assay genotoxicity studies using L-929 
(normal mouse epithelial) cells. 
An in vivo implantation study involving New Zealand 
White rabbits were carried out in the course of this 
study. 
 
Materials and Methods: HA granules of between 250 
to 500 μm in diameter were implanted into a 9mm by 
4.5mm defect made in the proximal metaphyseal region 
of the rabbits’ left tibia. The tibia was harvested at 2, 3, 
4, 6 and 12 weeks. The retrieved specimens were 
processed to produce undecalcified tissue sections using 
a hard tissue band cutting and microgrinding system 
(EXAKT Apparatebau, Germany). Prepared slides were 
analyzed under the light microscope using compound 
polarized light, Toulidine Blue, Masson Goldner’s 
Trichrome and von Kossa stains.  
 
Results and Discussion: New bone formation is seen 
even at 2 weeks post-implantation, which further 
consolidates at 3, 4 and 6 weeks. At 12 weeks the new 
bone between the granules are well-formed and the 
cortical defects made have closed off with well-formed 
lamellar bone seen between the granules. There is direct 
apposition of the new bone to the granules. The new 
bone seen with bridging of the medullary cavity and no 
major voids or defects found. No evidence of any 
fibrous or inflammatory tissue was seen. 
 
Conclusions: GranuMaS™ is osteoconductive and 
biocompatible when implanted in rabbits. It could be 
used as an alternative bone graft substitute, as there is 
profound new bone formation in-between and around 
the granules. 
 
     
    
       Figure 1: 12 weeks post implantation seen     
       under compound polarized light  
       (magnification 2.5x) 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
        Figure 2: Masson Goldner’s Trichrome at  
        3 weeks of implantation.  
        (HA – hydroxyapatite, O –osteocytes at  
        10X and 100X magnification) 
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